Academic Bibliography

Show Sort by

Your filters: cql: author="Schleiermacher, Gudrun" or (type exact bookEditor and editor="Schleiermacher, Gudrun")

Mark
- journalArticle
- open access
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study

Daniel A. Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, et al.

(2018) Pediatric Blood & Cancer. 65(11).
Mark
- journalArticle
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt (UGent) , Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2018) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 110(10).
Mark
- conference
- C3
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Pauline Depuydt (UGent) , Valentina Boeva, Toby Hocking, Robrecht Cannoodt (UGent) , Inge Ambros, Peter Ambros, Shahab Asgharzadeh, Edward Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Big Data in Biology and Health, Abstracts.
Mark
Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

Lucas Moreno, Hubert Caron, Birgit Geoerger, Angelika Eggert, Gudrun Schleiermacher, Penelope Brock, Dominique Valteau-Couanet, Louis Chesler, Johannes Schulte, Katleen De Preter (UGent) , et al.

(2017) EXPERT OPINION ON DRUG DISCOVERY. 12(8). p.801-811
Mark
- conference
- C3
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt (UGent) , Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Cancer Genomics, 3rd EACR conference, Abstracts.
Mark
- conference
- C3
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) OncoPoint, 4th Research seminar, Abstracts.
Mark
- conference
- C3
Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients

Pauline Depuydt (UGent) , Valentina Boeva, Toby D Hocking, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, Matthias Fischer, Michael D Hogarty, et al.

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Mark
- journalArticle
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) ONCOTARGET. 7(2). p.1960-1972
Mark
- conference
- C3
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2015) European Cancer Epigenetics conference, 1st, Abstracts.
Mark
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, et al.

(2015) CLINICAL CANCER RESEARCH. 21(8). p.1904-1915

Academic Bibliography

Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study

Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

Contents

Support

Contact